Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Hydrogen Utopia International (HUI) by Tom Winnifrith in ShareProphets
- Avoid Topps Tiles (TPT) by Steve Moore in ShareProphets
- Avoid SIG (SHI) by Steve Moore in ShareProphets
- Sell Hemogenyx Pharmaceuticals (HEMO) by Tom Winnifrith in ShareProphets
- Watch Coca-Cola HBC AG (CDI) (CCH) by Kevin Godbold in The Motley Fool
- Buy Bluebird Mining Ventures Ltd NPV (DI) (BMV) by Hot Stock Rockets in ShareProphets
- Watch Wynnstay Group (WYN) by Steve Moore in ShareProphets
- Buy Carnival (CCL) by UBS
- Hold BP (BP.) by Mark David Hartley in The Motley Fool
- Buy Prudential (PRU) by Mark David Hartley in The Motley Fool
- Outperform Phoenix Group Holdings (PHNX) by Exane
- Underperform Aviva (AV.) by Exane
- Neutral M&G (MNG) by Exane
- Hold S4 Capital (SFOR) by Deutsche Bank
- Neutral GSK (GSK) by Goldman Sachs
- Neutral Pennon Group (PNN) by Goldman Sachs
- Underweight British American Tobacco (BATS) by Morgan Stanley
- Neutral National Grid (NG.) by Citi
- Underweight Old Mutual Limited NPV (DI) (OMU) by Barclays
- Buy Baltic Classifieds Group (BCG) by Berenberg
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,349 open tips for GSK (GSK)
| Latest Bid : 1,460.00p | Latest Ask : 1,461.00p |
| High Today : 1,489.50p | Low Today : 1,455.94p |
| This Years High : 1,812.50p | This Years Low : 1,382.00p |
| Volume : 5,271,412 | MKT Cap : £60558.45M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Neutral | Goldman Sachs | Premium Only | 2024-10-03 06:20:00 03/10/2024 | – |
| Buy | Jefferies | Premium Only | 2024-10-03 04:55:00 03/10/2024 | -1.82% |
| Equal Weight | Barclays | Premium Only | 2024-10-01 05:50:00 01/10/2024 | -3.31% |
| Buy | Simon Watkins | Premium Only | 2024-09-09 07:35:00 09/09/2024 | -12.31% |
| Buy | Deutsche Bank | Premium Only | 2024-09-03 16:30:00 03/09/2024 | -12.18% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,460.00p | Latest Ask : 1,461.00p |
| High Today : 1,489.50p | Low Today : 1,455.94p |
| This Years High : 1,812.50p | This Years Low : 1,382.00p |
| Volume : 5,271,412 | MKT Cap : £60558.45M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Neutral | Goldman Sachs | Premium Only | 2024-10-03 06:20:00 03/10/2024 | – |
| Buy | Jefferies | Premium Only | 2024-10-03 04:55:00 03/10/2024 | -1.82% |
| Equal Weight | Barclays | Premium Only | 2024-10-01 05:50:00 01/10/2024 | -3.31% |
| Buy | Simon Watkins | Premium Only | 2024-09-09 07:35:00 09/09/2024 | -12.31% |
| Buy | Deutsche Bank | Premium Only | 2024-09-03 16:30:00 03/09/2024 | -12.18% |